LPCN insider disclosures
Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source | Follow |
|---|---|---|---|---|---|---|---|
| Higuchi John W. Director · Lipocine Inc. | LPCN Lipocine Inc. | BuyFiling detailsSEC transaction code P Common stock · Direct ownership · Reported balance after transaction: 391365 · SEC code covers open-market or private transactions | 2026-11-20 | 2026-11-20 | ≈ $111,832.50 75,000 shares/units | SEC 4 | Follow |
| Higuchi John W. Director · Lipocine Inc. | LPCN Lipocine Inc. | BuyFiling detailsSEC transaction code P Common stock · Direct ownership · Reported balance after transaction: 316365 · SEC code covers open-market or private transactions | 2026-11-19 | 2026-11-20 | ≈ $113,392.50 75,000 shares/units | SEC 4 | Follow |
| Patel Mahesh V. Chief Executive Officer · Director · Lipocine Inc. | LPCN Lipocine Inc. | BuyFiling detailsSEC transaction code P Common stock · Direct ownership · Reported balance after transaction: 211495 · SEC code covers open-market or private transactions | 2026-11-13 | 2026-11-13 | ≈ $39,997.50 25,000 shares/units | SEC 4 | Follow |
| Patel Mahesh V. Chief Executive Officer · Director · Lipocine Inc. | LPCN Lipocine Inc. | BuyFiling detailsSEC transaction code P Common stock · Direct ownership · Reported balance after transaction: 186495 · SEC code covers open-market or private transactions | 2026-11-12 | 2026-11-13 | ≈ $39,490.00 25,000 shares/units | SEC 4 | Follow |
Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.